Higher Inflammation From Early Adulthood Linked to Worse Cognition
By Elana Gotkine HealthDay Reporter
MONDAY, July 8, 2024 -- Worse midlife executive function and processing speed are seen with consistently higher or moderate/increasing inflammation starting in early adulthood, according to a study published online July 3 in Neurology.
Amber L. Bahorik, Ph.D., from the University of California in San Francisco, and colleagues used data from the Coronary Artery Risk Development in Young Adults study to identify inflammation trajectories (C-reactive protein [CRP] levels <10 mg/L) over 18 years through early adulthood (age, 24 to 58 years). Six cognitive domains were assessed, with the primary outcome of poor cognitive performance, defined as a decline of at least one standard deviation than the mean on each domain. Data were included for 2,364 participants (mean age, 50.2 years).
During 18 years, there were three CPR trajectories: low stable, moderate/increasing, and consistently higher (45, 16, and 39 percent, respectively). The researchers found that consistently higher and moderate/increasing CRP levels were associated with higher odds of poor processing speed compared with lower stable CRP; in addition, higher odds of poor executive function were seen in association with consistently higher CRP. No associations were seen for moderate/increasing and consistently higher CRP with memory, letter fluency, category fluency, or global cognition.
"Our results indicate that higher or increasing inflammation trajectories may be associated with (or influence) higher odds of poor cognitive function at midlife," the authors write.
One author disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
WEDNESDAY, May 21, 2025 -- For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.